Paolo Avanzini
Paolo Avanzini
Arcispedale Santa Maria Nuova - IRCCS - Reggio Emilia
Verified email at asmn.re.it
Title
Cited by
Cited by
Year
Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 …
EN Oliva, C Alati, V Santini, A Poloni, A Molteni, P Niscola, F Salvi, ...
The Lancet Haematology 4 (3), e127-e136, 2017
742017
Differences among young adults, adults and elderly chronic myeloid leukemia patients
F Castagnetti, G Gugliotta, M Baccarani, M Breccia, G Specchia, L Levato, ...
Annals of Oncology 26 (1), 185-192, 2015
512015
Multicentre phase III trial on fludarabine, cytarabine (Ara‐C), and idarubicin versus idarubicin, Ara‐C and etoposide for induction treatment of younger, newly …
D Russo, M Malagola, A de Vivo, M Fiacchini, G Martinelli, PP Piccaluga, ...
British journal of haematology 131 (2), 172-179, 2005
472005
Adherence and future discontinuation of tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia. A patient-based survey on 1133 patients
M Breccia, F Efficace, S Sica, E Abruzzese, M Cedrone, D Turri, M Gobbi, ...
Leukemia research 39 (10), 1055-1059, 2015
422015
MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavorably presenting Hodgkin's disease: A report from the Italian Lymphoma Study Group.
PG Gobbi, C Pieresca, M Federico, N Di Renzo, F Narni, E Iannitto, ...
Journal of clinical oncology 11 (4), 712-719, 1993
351993
Imatinib in very elderly patients with chronic myeloid leukemia in chronic phase: a retrospective study
R Latagliata, D Ferrero, A Iurlo, F Cavazzini, F Castagnetti, E Abruzzese, ...
Drugs & aging 30 (8), 629-637, 2013
342013
Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL
M Federico, V Clò, M Brugiatelli, M Carotenuto, PG Gobbi, D Vallisa, ...
Haematologica 83 (9), 800-811, 1998
301998
Vinblastine, bleomycin, and methotrexate chemotherapy plus extended-field radiotherapy in early, favorably presenting, clinically staged Hodgkin's patients: the Gruppo Italiano …
PG Gobbi, C Pieresca, A Frassoldati, M Carotenuto, N Di Renzo, ...
Journal of clinical oncology 14 (2), 527-533, 1996
301996
ProMECE-CytaBOM vs MACOP-B in advanced aggressive non-Hodgkin's lymphoma: long term results of a multicenter study of the Italian Lymphoma Study Group (GISL)
V Silingardi, M Federico, L Cavanna, P Avanzini, PG Gobbi, M Lombardo, ...
Leukemia & lymphoma 17 (3-4), 313-320, 1995
271995
ProMACE-cytaBOM versus MACOP-B in intermediate and high grade NHL. Preliminary results of a prospective randomized trial.
M Federico, G Moretti, PG Gobbi, P Avanzini, L Cavanna, M Carotenuto, ...
Leukemia 5, 95-101, 1991
201991
Serum selenium concentrations in patients with newly diagnosed lymphoid malignancies
P Avanzini, M Vinceti, F Ilariucci, L Masini, M D'Inca, G Vivoli
Haematologica 80 (6), 505-511, 1995
191995
Nilotinib 300 mg twice daily: an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patients
F Castagnetti, M Breccia, G Gugliotta, B Martino, M D’Adda, F Stagno, ...
haematologica 101 (10), 1200-1207, 2016
182016
Effects of thymostimulin with combination chemotherapy in patients with aggressive non-Hodgkin's lymphoma. A report from the Italian Lymphoma Study Group (GISL).
M Federico, PG Gobbi, G Moretti, P Avanzini, NR Di, L Cavanna, E Ascari, ...
American journal of clinical oncology 18 (1), 8-14, 1995
171995
Anaplastic large cell lymphoma (CD30+/Ki-1+). Analysis of 35 cases followed at GISL centres
G Longo, M Federico, C Pieresca, P Avanzini, E Iannitto, AU Di Prisco, ...
European Journal of Cancer 31 (11), 1763-1767, 1995
161995
EVALUATING SURVIVAL AFTER ALLOGENEIC BONE-MARROW TRANSPLANT FOR CHRONIC MYELOID-LEUKEMIA IN CHRONIC PHASE-A COMPARISON OF TRANSPLANT VERSUS NO-TRANSPLANT IN A COHORT OF 258 …
S Tura, R Fanin, D Russo, F Zuffa, M Fiacchini, M Baccarani, N Testoni, ...
Wiley-Blackwell 85 (2), 292-299, 1993
161993
A pilot study on the use of the proMACE‐cytaBOM regimen as a first‐line treatment of advanced follicular non‐Hodgkin's lymphoma
L Baldini, A Guffanti, P Gobbi, M Colombi, M Federico, P Avanzini, ...
Cancer 79 (6), 1234-1240, 1997
141997
Eltrombopag for the treatment of thrombocytopenia of low and intermediate-1 IPSS risk myelodysplastic syndromes: interim results on efficacy, safety and quality of life of an …
EN Oliva, V Santini, C Alati, A Poloni, A Molteni, P Niscola, G Sanpaolo, ...
Blood, The Journal of the American Society of Hematology 126 (23), 91-91, 2015
132015
Retrospective analysis of mantle cell lymphoma: experience of the" Gruppo Italiano per lo Studio dei Linfomi"(GISL)
V Callea, V Clò, F Morabito, L Baldini, C Stelitano, F Narni, P Avanzini, ...
Haematologica 83 (11), 993-997, 1998
131998
Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcome
A Iurlo, A Nobili, R Latagliata, C Bucelli, F Castagnetti, M Breccia, ...
Oncotarget 7 (48), 80083, 2016
122016
EPIDOXORUBICIN VS IDARUBICIN CONTAINING REGIMENS IN INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA-PRELIMINARY-RESULTS OF A MULTICENTRIC RANDOMIZED TRIAL
M Brugiatelli, M Federico, PG Gobbi, P AvANZINI, V Callea, L Cavanna, ...
111993
The system can't perform the operation now. Try again later.
Articles 1–20